Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| classical monocyte | 7 studies | 24% ± 7% | |
| non-classical monocyte | 7 studies | 26% ± 9% | |
| myeloid cell | 3 studies | 19% ± 3% | |
| B cell | 3 studies | 17% ± 0% | |
| dendritic cell | 3 studies | 28% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 4 studies | 17% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 3032.19 | 578 / 578 | 100% | 27.19 | 1155 / 1155 |
| thymus | 100% | 1589.98 | 653 / 653 | 100% | 23.64 | 604 / 605 |
| skin | 100% | 1042.17 | 1808 / 1809 | 100% | 27.07 | 471 / 472 |
| breast | 100% | 997.36 | 459 / 459 | 99% | 24.49 | 1105 / 1118 |
| uterus | 99% | 614.11 | 169 / 170 | 99% | 22.38 | 455 / 459 |
| stomach | 99% | 1260.03 | 354 / 359 | 100% | 35.11 | 285 / 286 |
| prostate | 99% | 1001.56 | 242 / 245 | 98% | 14.70 | 490 / 502 |
| intestine | 96% | 1682.32 | 931 / 966 | 100% | 33.04 | 526 / 527 |
| bladder | 95% | 1089.62 | 20 / 21 | 100% | 33.57 | 502 / 504 |
| esophagus | 93% | 771.82 | 1343 / 1445 | 100% | 32.33 | 183 / 183 |
| pancreas | 93% | 583.73 | 305 / 328 | 99% | 30.30 | 176 / 178 |
| ovary | 87% | 432.56 | 156 / 180 | 100% | 26.23 | 428 / 430 |
| kidney | 87% | 680.30 | 77 / 89 | 93% | 16.49 | 838 / 901 |
| adrenal gland | 90% | 547.56 | 232 / 258 | 72% | 10.17 | 165 / 230 |
| brain | 54% | 281.77 | 1420 / 2642 | 99% | 19.87 | 698 / 705 |
| liver | 71% | 392.49 | 160 / 226 | 60% | 8.33 | 245 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 119.36 | 29 / 29 |
| peripheral blood | 100% | 16668.11 | 929 / 929 | 0% | 0 | 0 / 0 |
| spleen | 100% | 9170.76 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 28.93 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 18.52 | 1 / 1 |
| adipose | 100% | 1257.89 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 94% | 12.79 | 75 / 80 |
| blood vessel | 87% | 672.10 | 1160 / 1335 | 0% | 0 | 0 / 0 |
| heart | 47% | 231.13 | 407 / 861 | 0% | 0 | 0 / 0 |
| muscle | 5% | 18.27 | 40 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0034260 | Biological process | negative regulation of GTPase activity |
| GO_0090630 | Biological process | activation of GTPase activity |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005096 | Molecular function | GTPase activator activity |
| Gene name | GMIP |
| Protein name | GEM interacting protein GEM-interacting protein (GMIP) GMIP |
| Synonyms | |
| Description | FUNCTION: Stimulates, in vitro and in vivo, the GTPase activity of RhoA. . |
| Accessions | ENST00000203556.9 [Q9P107-1] ENST00000591047.1 ENST00000587205.1 A0A024R7N1 ENST00000588171.5 K7EJC2 ENST00000587238.5 [Q9P107-2] Q9P107 K7EQR5 K7ELE8 ENST00000593186.1 |